ACRIVON THERAPEUTICS, INC.
ACRIVON THERAPEUTICS, INC. is a registered legal entity registered in United States under 6795324, and its current status with Delaware Division of Corporations is active. The company was incorporated on 3 January 2019 and lists its registered address as United States. 5 shareholders are on record for ACRIVON THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for ACRIVON THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 4.3% — the largest recorded stake — followed by Acorn Capital Advisors, LLC at 2.3%; the remaining 3 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 4.3% | Delaware Division of Corporations | |
| Acorn Capital Advisors, LLC | 2.3% | Delaware Division of Corporations | |
| UBS Group AG | 2.1% | Delaware Division of Corporations | |
| iShares Trust-iShares Micro-Cap ETF | 0.2% | Delaware Division of Corporations | |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 0% | Delaware Division of Corporations |
Officers
5
The Co-founder, Chairman Of The Board, Ceo, President & Acting Chief Scientific Officer of ACRIVON THERAPEUTICS, INC. currently on record is Peter Blume-jensen M.d., Ph.d.; five officers are currently on record for ACRIVON THERAPEUTICS, INC., filed with Delaware Division of Corporations.
The register reports 13 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at ACRIVON THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
ACRIVON THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States, Sweden jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
ACRIVON THERAPEUTICS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns ACRIVON THERAPEUTICS, INC.?
Five shareholders are currently on record for ACRIVON THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 4.3% — the largest recorded stake — followed by Acorn Capital Advisors, LLC at 2.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is ACRIVON THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for ACRIVON THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does ACRIVON THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for ACRIVON THERAPEUTICS, INC..
What is ACRIVON THERAPEUTICS, INC.'s company registration number?
ACRIVON THERAPEUTICS, INC.'s registration number is 6795324, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is ACRIVON THERAPEUTICS, INC. still an active company?
ACRIVON THERAPEUTICS, INC.'s status on Delaware Division of Corporations is listed as active.
When was ACRIVON THERAPEUTICS, INC. incorporated?
ACRIVON THERAPEUTICS, INC. was incorporated on 3 January 2019, according to Delaware Division of Corporations.
What is ACRIVON THERAPEUTICS, INC.'s registered address?
The registered address on file for ACRIVON THERAPEUTICS, INC. is United States.
Who are the officers/directors of ACRIVON THERAPEUTICS, INC.?
The Co-founder, Chairman Of The Board, Ceo, President & Acting Chief Scientific Officer of ACRIVON THERAPEUTICS, INC. currently on record is Peter Blume-jensen M.d., Ph.d.; five officers are currently on record for ACRIVON THERAPEUTICS, INC., filed with Delaware Division of Corporations. Management authority at ACRIVON THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does ACRIVON THERAPEUTICS, INC. have a parent company or subsidiaries?
ACRIVON THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span United States, Sweden jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to ACRIVON THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to ACRIVON THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access ACRIVON THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like ACRIVON THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.